Tokyo Tape
Sign in
← Manac Chemical Partners

Quarterly report · Q3

4360.TEDINET S100SO8N
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥6.9bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥11.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥8.7bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income−¥142m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥819m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income−¥70m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥1.2bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥991m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥20m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥1.1bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥3m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥821m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥809m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥02023-04-01 → 2023-12-31Cons.Profit loss
Net income¥809m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥14.3bnat 2023-12-31Cons.Assets
Total assets¥15.0bnat 2023-03-31Cons.Assets
Total assets¥15.5bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥3.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥4.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥11.1bnat 2023-12-31Cons.Net assets
Net assets / equity¥11.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥11.0bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥3.2bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥3.7bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥-0.42023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.052023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥103.262022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥101.92022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥53.492022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio77.4%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio71.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
jpcrp040300-q3r_E36769-000Fine Chemical Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥2.5bn
jpcrp040300-q3r_E36769-000Fine Chemical Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥2.5bn
jpcrp040300-q3r_E36769-000Fine Chemical Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥359m
jpcrp040300-q3r_E36769-000Flame Retardants Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥3.4bn
jpcrp040300-q3r_E36769-000Flame Retardants Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥3.4bn
jpcrp040300-q3r_E36769-000Flame Retardants Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥300m
jpcrp040300-q3r_E36769-000Health Support Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥1.0bn
jpcrp040300-q3r_E36769-000Health Support Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.0bn
jpcrp040300-q3r_E36769-000Health Support Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥46m
—segment totalrevenue2023-04-01 → 2023-12-31¥6.9bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥6.9bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥706m
jpcrp040300-q3r_E36769-000Fine Chemical Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥3.0bn
jpcrp040300-q3r_E36769-000Fine Chemical Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥3.0bn
jpcrp040300-q3r_E36769-000Fine Chemical Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥443m
jpcrp040300-q3r_E36769-000Flame Retardants Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥4.7bn
jpcrp040300-q3r_E36769-000Flame Retardants Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥4.7bn
jpcrp040300-q3r_E36769-000Flame Retardants Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E36769-000Health Support Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥940m
jpcrp040300-q3r_E36769-000Health Support Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥940m
jpcrp040300-q3r_E36769-000Health Support Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥17m
—segment totalrevenue2022-04-01 → 2022-12-31¥8.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥8.7bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥1.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 332
ItemContextValueUnit
Accounts payable tradePrior1YearInstant2361000000JPY
Accounts payable tradeCurrentQuarterInstant1979000000JPY
Short term loans payablePrior1YearInstant290000000JPY
Short term loans payableCurrentQuarterInstant332000000JPY
Income taxes payablePrior1YearInstant210000000JPY
Income taxes payableCurrentQuarterInstant7000000JPY
Provision for bonusesPrior1YearInstant173000000JPY
Provision for bonusesCurrentQuarterInstant81000000JPY
Other clPrior1YearInstant855000000JPY
Other clCurrentQuarterInstant710000000JPY
Current liabilitiesPrior1YearInstant3891000000JPY
Current liabilitiesCurrentQuarterInstant3110000000JPY
Deferred tax liabilitiesPrior1YearInstant47000000JPY
Deferred tax liabilitiesCurrentQuarterInstant76000000JPY
Other nclPrior1YearInstant32000000JPY
Other nclCurrentQuarterInstant27000000JPY
Noncurrent liabilitiesPrior1YearInstant80000000JPY
Noncurrent liabilitiesCurrentQuarterInstant103000000JPY
LiabilitiesPrior1YearInstant3972000000JPY
LiabilitiesCurrentQuarterInstant3214000000JPY
Capital stockPrior1YearInstant300000000JPY
Capital stockCurrentQuarterInstant300000000JPY
Capital surplusPrior1YearInstant3459000000JPY
Capital surplusCurrentQuarterInstant3460000000JPY
Retained earningsPrior1YearInstant7566000000JPY
Retained earningsCurrentQuarterInstant7443000000JPY
Treasury stockPrior1YearInstant-474000000JPY
Treasury stockCurrentQuarterInstant-426000000JPY
Shareholders equityPrior1YearInstant10852000000JPY
Shareholders equityCurrentQuarterInstant10777000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant180000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant261000000JPY
Deferred gains or losses on hedgesPrior1YearInstant0JPY
Deferred gains or losses on hedgesCurrentQuarterInstant-0JPY
Foreign currency translation adjustmentPrior1YearInstant6000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant9000000JPY
Valuation and translation adjustmentsPrior1YearInstant187000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant270000000JPY
Non controlling interestsPrior1YearInstant－JPY
Non controlling interestsCurrentQuarterInstant7000000JPY
Net assetsPrior1YearInstant11039000000JPY
Net assetsCurrentQuarterInstant11055000000JPY
Liabilities and net assetsPrior1YearInstant15012000000JPY
Liabilities and net assetsCurrentQuarterInstant14269000000JPY
Net salesPrior1YTDDuration8657000000JPY
Net salesCurrentYTDDuration6937000000JPY
Cost of salesPrior1YTDDuration6488000000JPY
Cost of salesCurrentYTDDuration5629000000JPY
Gross profitPrior1YTDDuration2168000000JPY
Gross profitCurrentYTDDuration1308000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass